Companies/US/MBX

MBX BIOSCIENCES, INC.

Last · —$48.82-0.18 (-0.37%)live · yahoo · 9m ago
Vol 994.4K ≈ 48.55M
Market cap$2.44B—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session

Issuer

Legal nameMBX BIOSCIENCES, INC.
HQUnited States (US)
ListingUS MBX
ISINUS55287L1017
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001776111
CIK0001776111
Websitewww.mbxbio.com
LinkedIn
Employees63
AddressMBX Biosciences, Inc. 11711 North Meridian Street 46032, Carmel
Loading chart…

Upcoming earnings

1 event
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.84
Est. revenue
0
View upcoming earnings →

Press & signals

3 recent
  • GlobeNewswire

    MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer

  • GlobeNewswire

    MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights

  • GlobeNewswire

    MBX Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth

Documents

FormReporting forFiledFlags
8-KCurrent Report (8-K)
—2026-08-270
8-K8-K: Results of Operations and Financial Condition
—2026-08-060
10-Q
2026-06-302026-08-06 2
8-K8-K: Departure of Directors or Certain Officers; Election of Directors
2026-07-092026-07-130
Showing 4 of 4 filings